WASHINGTON, DC – A diverse coalition of consumer advocacy groups, free market organizations, family and faith groups, drug policy reformers, and public policy advocates implore Congress to oppose HR 8000,...
While the instinct to regulate is an appropriate one, the tool of prohibition is a costly one. The lesson of the 2016 fight to keep kratom off the DEA’s scheduling...
The legacy kratom manufacturing industry is reaching for the same tactics that almost banned their products and had their consumers criminalized a decade ago. There’s a unique twist in the...
When authorities moved to schedule kratom, they triggered a public health scare, not a safety fix. When the federal government attempted to use its regulatory authority to schedule the popular...
Ohio Board of Pharmacy Common Sense Initiative Public Comment Proposed Rule 4729:9-1-01.1: Mitragynine-Related Compounds January 28, 2026 As a consumer advocacy group that fights for lifestyle freedom, innovative technologies, and...
COLUMBUS, OH – On Thursday, Ohio Governor Mike DeWine announced he is formally requesting the Ohio Board of Pharmacy to use an emergency rule to outlaw kratom alkaloids including 7-hydroxymitragynine...
WASHINGTON, DC – On Tuesday in Kansas City, Missouri, agents of the Department of Justice, U.S. Marshals Service, and Food and Drug Administration conducted a raid and seizure of more than 73,000 units...
A coalition of consumer advocacy, free market, and drug policy reform groups oppose measures to prohibit and ban kratom-derived 7-OH products. WASHINGTON, DC – A diverse coalition of consumer advocacy...
HARTFORD, CT. – Today, the Connecticut Department of Consumer Protection will consider the scheduling of certain substances as requested by the General Assembly earlier this year. The expansive list includes...
WASHINGTON, D.C. – Today, the Consumer Choice Center launched a new policy primer offering smart approaches and a regulatory framework for 7-OH and kratom derivatives, a series of compounds and...
